Pharmaceutical Industry News Archive
Get news by email or subscribe to our news feeds.
News Archive for November 2010
November 1, 2010
- Pfizer Recalls More Lipitor Over Odors
- Glaxo Recalls 1 Lot Of Emo-Cort Lotion In Canada
- J&J Probes Crucell's Manufacturing Mishap
- Nycomed to Accelerate Expansion in China Through Acquisition of Majority Stake in Guangdong Techpool Bio-Pharma
- Valeant Pharmaceuticals and Kadmon Announce Strategic Agreement for Antiviral Therapeutics
- Specialised therapeutics and Helsinn Group Announce a PBS Listing for Aloxi (Palonosetron) in Australia
- J&J Probes Crucell's Manufacturing Mishap
- Pfizer Ranks at the Top In Philanthropy
November 2, 2010
- FDA, University of Rochester Announce Partnership for New Drug Products
- Pfizer Reports Third-Quarter 2010 Results
- Teva Reports Record Third Quarter 2010 Results
- BIO and AUTM File Joint Brief Defending Patentability of DNA-Based Inventions
- Amgen to Provide Testimony at FDA Hearing on Biosimilars
- Arthritis Foundation Patient Advocate to Testify at FDA Hearing on Approval Pathway for Biosimilars
- Attorney General Caldwell Sues Drug Companies for Overcharging Louisiana Medicaid
- Pfizer Net Income Falls 70%
- Lilly To Open Diabetes Research Center In China
- J&J, Watson Sign Deal For Generic Concerta
- SEC Charges Medical Researcher With Tipping Inside Information About Clinical Trial
November 3, 2010
- FDA Extends Review of Bristol-Myers Melanoma Drug
- French Doctor Arrested on Charges he Fed Inside Tips from a Drug Trial to a Hedge Fund Manager
- Biogen Idec Announces Framework for Growth Through Increased Focus and Efficiency
- H. Lundbeck A/S (DK) - Third quarter report 2010 -- Continued strong growth in third quarter - 2010 results to be at the high end of guidance range
- Lundbeck Expects to Deliver Solid Profits During A Period of New Product Launches and Patent Expiries
- Cadence Says FDA Approves Ofirmev
- Judge Consolidates King Lawsuits
- Biogen Idec Outlines Restructuring Plan
November 4, 2010
- Watson Q3 Net Revenue Climbs 33 Percent to $882 Million
- Dendreon Takes Bigger 3Q Loss, Provenge Sales Rise
- Bristol-Myers, Simcere Sign Development Deal
- Bristol-Myers To Repurchase $750M In Debt
- PhRMA Statement on the FDA Approving Biosimilars
- Biogen Idec and Cardiokine Dissolve Collaboration for Lixivaptan
- Charles River Announces Third-Quarter 2010 Results
- Group Says Anti-Lilly Billboards Rejected
- Synta Pharma Books 3Q Loss After Partnership Ends
November 5, 2010
- MannKind Corporation Issues Statement on Lawsuit
- Arena Pharmaceuticals Provides Update on GPR119 Portfolio for Type 2 Diabetes
- Amylin Posts Bigger 3Q Loss As Byetta Sales Slip
November 8, 2010
- Stonefly Communications Group Joins GSW Worldwide
- Lilly to Acquire Avid Radiopharmaceuticals
- AstraZeneca, Bristol-Myers Diabetes Drug Approved
- Sanofi-aventis Sends Letter to Genzyme Seeking Clarification on Potential Board Actions
- Siga to Appeal Adverse Small Business Size Determination
- Lilly Spending $800M On Firm With Alzheimer's Drug Pipeline
- Genzyme Responds to Sanofi-Aventis Letter
November 9, 2010
- Sanofi To Genzyme: It's Time To Talk, Not Fight
- Biotech Aid Falls Flat
- Doctors Cut Some Drug Company Ties Amid Rising Scrutiny, But Freebies Still Common
- Santarus Reports 3Q Loss On Sales Drop, Costs
- Micromet Narrows 3Q Loss As Revenue Rises
- Paris Pharma Events Smash All Attendance Records
November 10, 2010
- Ex-Glaxo Attorney Charged With Obstruction
- Forest Laboratories, Inc. Announces Executive Management Promotions and Retirement of Lawrence Olanoff as President and Chief Operating Officer
- Pharmaceutical Company Lawyer Charged with Obstruction and Making False Statements
- FDA: Majority of drug and biological product makers meeting postmarketing requirements and commitments
- Pfizer Starts New Research Collaboration With Biovista
- Ex-Glaxo Attorney Charged With Obstruction
- Amarin Names Chairman Joseph S. Zakrzewski As CEO
- Review Says Momenta's Aid Taints FDA's OK of Heparin
November 11, 2010
- Novartis Takes $120 Million Hit From Failed Drug Trial
- AlphaRx Announces New Advantageous Corporate Developments
- Forest Laboratories, Inc. Announces Executive Management Promotions and Retirement of Lawrence Olanoff as President and Chief Operating Officer
November 12, 2010
- Big Pharma Gearing Up To Face The Patent Cliff
- Geron Stock Climbs After Trial Findings Announced
- Celsion Drug Gets 'Orphan Drug' Status In Europe
- Nearly 700 drugs in development for oncology, the top area of research: PharmaLive Special Reports
November 15, 2010
- Penn-Led International Study Finds No Difference In Nonsuicide Mortality Between Two Anti-Psychotic Drugs
- Ineffective Drug Shows Flawed Test Process
- Recording Of Apparent Collusion In Mexico Pharmaceutical Industry Sparks Probes Suspensions
- Lupus Drug At Pivotal Stage
- FDA More Cautious About Drug Safety
- FDA Urges Consumers to be 'Smart' about Antibiotic Use
- FDA Approves New Treatment Option for Late-Stage Breast Cancer
November 16, 2010
- More Than Two-Thirds of U.S. Consumers Seek Medical Advice Via the Internet and Social Media, Accenture Study Finds
- Eisai Can Sell Breast-Cancer Drug
- Pfizer Adding Heavily to Layoffs
- Profit, Sales Rise At Trimeris
- Court Upholds Lilly's Alimta Patent
- Anthera Suspends Enrollment and Dosing in PEARL-SC Clinical Trial to Address Reports of Vial Problems
- Federal Court Upholds Otsuka's Abilify Patent
- Boomers Spend 150+ Minutes/Month on Facebook; Twitter Makes Top 10 List
November 17, 2010
- SDI Reports: 150 Pharmaceutical Brands New to ePromotion in 2010
- Drug Companies Accused Of Exploiting Rules on Treatments for Rare Diseases
- KV Pharmaceutical Exec Banned From Federal Health Care Programs
- Roche to Cut 4,800 Jobs Over 2 Years to Help Save $2.4 Billion
- Novartis Unveils Long-Term Strategy to Grow in A Dynamically Changing Healthcare Environment
- Roche Announces Implementation Plans for Its Operational Excellence Program
- Survey: 94% of Docs Report Patients Rationing, Forgoing Meds and Treatments in Past Six Months
- Lundbeck Names Staffan Schüberg as President of Lundbeck Inc. U.S. Subsidiary
November 18, 2010
- V3381 Programme Update
- Cardinal Health To Acquire Kinray for $1.3 Billion
- Roche Madison Scheduled To Close By End of 2011, Eliminating Up To 45 Jobs
- Roche Selling Boulder Facility In Companywide Cost-Cutting Move
- New Merck Drug Drops Bad, Raises Good Cholesterol To Record Levels: Study
- Bristol-Myers Squibb Sued for Denying Overtime Pay
- Bristol-Myers Squibb Sued for Denying Employees Overtime Pay
- FDA Panel Backs New Use For Gardasil Vaccine
November 19, 2010
- APPRAISE-2 Study with Investigational Compound Apixaban in Acute Coronary Syndrome Discontinued
- Heart Drug Raises Questions
- Bayer Focuses Resources on Growth and Innovation
- W.Va. High Court Reverses Ruling Against Drug Maker
November 21, 2010
November 22, 2010
- f-star and Boehringer Ingelheim to Collaborate in Discovery and Development of Therapeutic Antibodies
- Pfizer Extends Tender Offer to Acquire King Pharmaceuticals, Inc.
- Cancer Drug Running Short In Anchorage
- Merck Gets Good News From Vytorin Study
- Regeneron/Bayer Eye Drug Works As Well as Lucentis
November 23, 2010
- BioDelivery Sciences Announces Resumption of Onsolis Manufacturing
- Area Hospitals Dealing With Drug Shortages
- The United States of Diabetes: New Report Shows Half the Country Could Have Diabetes or Prediabetes at a Cost of $3.35 Trillion by 2020
- Gilead Asks FDA to Approve New HIV Drug Combo
- CNS Therapeutics Gets FDA Nod
- Department Of Justice Recovers $3 Billion in False Claims Cases in Fiscal Year 2010
- Tranzyme Plans Stock Offering
- GlaxoSmithKline and Dr. Reddy's Agree to the Sale of US Penicillin Facility and Products
- CDD, U.S. PIRG, Consumer Watchdog, and World Privacy Forum Call on FTC to Investigate Interactive Marketing of Pharmaceutical and Health Products and Services to Consumers and Health Professionals
November 24, 2010
- NICE Guidance Recommends a New Treatment for Certain Patients with Metastatic Gastric Cancer
- Genzyme Successfully Meets First Milestones of FDA Consent Decree
November 29, 2010
- Glaxo to Increase Theravance Shareholding
- AMAG Pharmaceuticals Announces Update to Feraheme Label
- FDA Reviews 2 New Drugs To Reduce Prostate Cancer
- Basilea awarded USD 130 million by arbitral tribunal
- Merck KGaA Announces Extension of FDA Priority Review Period for Cladribine Tablets for the Treatment of Relapsing Forms of MS
- GlaxoSmithKline to Increase Its Shareholding in Theravance
- Merck To Stop Late-Stage Study Of HIV Treatment
- Amag Shares Rise As Feraheme Agreement Announced
November 30, 2010
- Merck Board Elects Kenneth C. Frazier as Next CEO; Richard T. Clark to Continue as Chairman
- SDI Reports: GlaxoSmithKline Sales Force No. 1 with Primary Care Physicians
- European Medicines Agency Widens Public Access to Documents
- Impax Says J&J Filed Suit Over ADHD Drug Patent
- Simcere Pharmaceutical Group Provides Update on Jiangsu Yanshen
- Novartis Pharmaceuticals Corporation Restructuring US Field Force to Align With Changing Product Portfolio and Strategic Growth Priorities
